Goldman Sachs’s Achaogen Inc AKAO Stock Holding History

Goldman Sachs’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-55,000	Closed	-$476K	–	5941
2018 Q2	$476K	Buy	+55,000	New	+$670K	﹤0.01%	4537

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs's AKAO Position: Q4 2018 in Review

Goldman Sachs sold out of Achaogen Inc (AKAO) in Q4 2018, closing a stake of 219,375 shares — an estimated $875K sold.

Goldman Sachs first reported a position in AKAO in Q1 2015 and held it in 14 quarters. The position peaked at $5.13M in Q3 2017. 78 funds tracked by Wall St. Rank hold AKAO as of Q4 2018.

Goldman Sachs reported no remaining Achaogen Inc position as of Q4 2018 after selling out during the quarter.
Goldman Sachs sold 219,375 Achaogen Inc shares in Q4 2018, an estimated $875K.
Goldman Sachs first reported a position in Achaogen Inc in Q1 2015 and held it in 14 quarters.
Goldman Sachs's Achaogen Inc position peaked at $5.13M in Q3 2017.
78 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2018.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.